Literature DB >> 1880658

Immediate improvement in lung volume after exogenous surfactant: alveolar recruitment versus increased distention.

L S Goldsmith1, J S Greenspan, S D Rubenstein, M R Wolfson, T H Shaffer.   

Abstract

To determine whether changes in lung volume may be responsible for the clinical improvement in preterm infants given exogenous surfactant, we measured functional residual capacity (FRC), lung mechanics, and partial pressure of oxygen in seven ventilated neonates (birth weight 1080 +/- 361 gm (mean +/- SD); gestational age 28.3 +/- 2.6 weeks) less than 9 hours of age who had findings typical of hyaline membrane disease. All patients received 100 mg/kg calf lung surfactant extract. FRC was measured by a closed-circuit helium-dilution technique, and lung mechanics were determined by least mean squares analysis. FRC increased in all patients (range 56% to 330%; p less than 0.03). Dynamic lung compliance and total airway conductance did not change. Mean +/- SEM specific lung compliance (dynamic lung compliance/FRC) decreased 55.93% +/- 4.27% (p less than 0.02) and mean specific conductance (total airway conductance/FRC) decreased 45.91% +/- 9.74% (p less than 0.009). Mean alveolar/arterial partial pressure of oxygen ratio decreased 51.0% +/- 8.67% (p less than 0.01). These data indicate that the immediate improvement in oxygenation after surfactant administration is related to increased lung volumes. The decrease in specific lung compliance and specific airway conductance is suggestive of increased distention rather than recruitment of functional alveoli.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1880658     DOI: 10.1016/s0022-3476(05)82057-8

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  15 in total

Review 1.  Long term sequelae of bronchopulmonary dysplasia (chronic lung disease of infancy).

Authors:  E Eber; M S Zach
Journal:  Thorax       Date:  2001-04       Impact factor: 9.139

Review 2.  Calfactant: a review of its use in neonatal respiratory distress syndrome.

Authors:  S V Onrust; M Dooley; K L Goa
Journal:  Paediatr Drugs       Date:  1999 Jul-Sep       Impact factor: 3.022

Review 3.  Role of lung function testing in the management of mechanically ventilated infants.

Authors:  A Schibler; U Frey
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-07       Impact factor: 5.747

4.  A risk-benefit assessment of natural and synthetic exogenous surfactants in the management of neonatal respiratory distress syndrome.

Authors:  H Walti; M Monset-Couchard
Journal:  Drug Saf       Date:  1998-05       Impact factor: 5.606

5.  Lung volume and pulmonary blood flow measurements following exogenous surfactant.

Authors:  J Alexander; A D Milner
Journal:  Eur J Pediatr       Date:  1995-05       Impact factor: 3.183

6.  Surfactant administration prior to one lung ventilation: physiological and inflammatory correlates in a piglet model.

Authors:  Rahul Bhatia; Thomas H Shaffer; Jobayer Hossain; Alicia Olivant Fisher; Liana M Horner; M Elena Rodriguez; Scott Penfil; Mary C Theroux
Journal:  Pediatr Pulmonol       Date:  2011-05-26

7.  How does exogenous surfactant really work?

Authors:  A D Milner
Journal:  Eur J Pediatr       Date:  1995       Impact factor: 3.183

8.  How does exogenous surfactant work?

Authors:  A D Milner
Journal:  Arch Dis Child       Date:  1993-03       Impact factor: 3.791

9.  Static respiratory compliance in the newborn. III: Early changes after exogenous surfactant treatment.

Authors:  B J Stenson; R M Glover; G J Parry; R A Wilkie; I A Laing; W O Tarnow-Mordi
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-01       Impact factor: 5.747

10.  Surfactant replacement therapy in acute respiratory distress syndrome from viral pneumonia.

Authors:  G Putz; C Hörmann; W Koller; G Schön
Journal:  Intensive Care Med       Date:  1996-06       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.